| Literature DB >> 26906286 |
T L Harris1, C J Wenthur1, A Diego-Taboada2, G Mackenzie2, T S Corbitt3, K D Janda1.
Abstract
3,4-Diaminopyridine has shown promise in reversing botulinum intoxication, but poor pharmacokinetics and a narrow therapeutic window limit its clinical utility. Thus, we developed a pH-dependent oral delivery platform using club moss spore exines. These exine microcapsules slowed 3,4-diaminopyridine absorption, limited its seizure activity, and enabled delivery of doses which prolonged mouse survival after botulism neurotoxin A intoxication.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26906286 PMCID: PMC7544009 DOI: 10.1039/c6cc00615a
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222